Inform Genomics Receives New Round

  • Feed Type
  • Date
    12/1/2011
  • Company Name
    Inform Genomics
  • Mailing Address
    75 State Street 9th Floor Boston, MA 02110
  • Company Description
    Our vision is to transform individual patient care & drug development with our predictive pharmacogenomic platform of products.
  • Website
    http://www.informgenomics.net
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Inform Genomics said that it would use the new capital mainly to move along development of its molecular diagnostic product called ONPART, which uses genomics to predict what side effects a specific cancer patient might encounter with chemotherapy treatments.
  • M&A Terms
  • Venture Investor
    Undisclosed